GUARDIAN THERAPEUTICS

guardian-therapeutics-logo

Guardian Therapeutics believe that the true potential of aptamer therapeutics is virtually unlimited and that we are the company to realize that potential.

#SimilarOrganizations #People #Website #More

GUARDIAN THERAPEUTICS

Industry:
Therapeutics

Founded:
2017-01-01

Address:
Lexington, Massachusetts, United States

Country:
United States

Website Url:
http://www.guardiantherapeutics.com

Total Employee:
51+

Status:
Active

Contact:
+1 781 918-6580

Email Addresses:
[email protected]

Total Funding:
30 M USD


Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

Current Employees Featured

joe-boncore_image

Joe Boncore
Joe Boncore Chief Executive Officer @ Guardian Therapeutics
Chief Executive Officer

kendalle-burlin-oconnell_image

Kendalle Burlin O&s;Connell
Kendalle Burlin O'Connell President & Chief Operating Officer @ Guardian Therapeutics
President & Chief Operating Officer
2008-10-01

james-c-gilbert_image

James C. Gilbert
James C. Gilbert Co-Founder & CEO @ Guardian Therapeutics
Co-Founder & CEO
2018-02-01

Founder


james-c-gilbert_image

James C. Gilbert

Official Site Inspections

http://www.guardiantherapeutics.com Semrush global rank: 1.01 M Semrush visits lastest month: 32.74 K

  • Host name: ip-173-201-182-144.ip.secureserver.net
  • IP address: 173.201.182.144
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Guardian Therapeutics"

Guardian Therapeutics

Aptamers are short nucleic acids that fold into distinct tertiary structures in order to recognize specific target molecules; At the molecular level, aptamers bind to their target site through …See details»

Guardian Therapeutics - Crunchbase Company Profile …

Aptamers: Short nucleic acids designed to bind specific target molecules with high affinity, used for therapeutic effects. Therapeutic Areas: Focus on …See details»

Guardian Therapeutics Inc | LinkedIn

Guardian Therapeutics Inc | 262 followers on LinkedIn. Guardian is an independent, family- and employee-owned biotech enterprise specialized in discovery and development of aptamer therapeutics.See details»

Guardian Therapeutics, LLC Company Profile | Lexington, MA ...

Find company research, competitor information, contact details & financial data for Guardian Therapeutics, LLC of Lexington, MA. Get the latest business insights from Dun & Bradstreet.See details»

Guardian Therapeutics Inc - Company Overview, Contact Info, …

Guardiantherapeutics.com Employees 9 Industry BioTech/Drugs. More Details. Financials & Stats . Revenue. $10B. More Financials. Who is Guardian Therapeutics Inc . Guardian Therapeutics …See details»

Guardian Therapeutics - MassBio

Guardian Therapeutics is a well-capitalized, privately owned drug discovery & development venture based in Cambridge, MA. We employ advanced aptamer technology to create novel …See details»

Guardian Therapeutics - PitchBook

Guardian Therapeutics General Information Description. Operator of a biotechnology company intended to discover and develop aptamer therapeutics. The company develops therapeutic technology from aptamers which are short …See details»

Guardian Therapeutics Inc - Company Profile & Staff Directory

Guardian is an independent, family- and employee-owned biotech enterprise specialized in discovery and development of aptamer therapeutics.See details»

Guardian Therapeutics Company Profile -Sales, Contacts, …

Guardian Therapeutics, Inc. (trade name Guardian Therapeutics) is in the Personal Appearance Services business. View competitors, revenue, employees, website and phone number.See details»

Guardian Therapeutics - VentureRadar

"Guardian is an independent, family- and employee-owned biotech enterprise specialized in discovery and development of aptamer therapeutics.Aptamers are short nucleic acids that bind …See details»

Our People - Guardian Therapeutics

Our People. Our senior leadership team comprises industry veterans with, in aggregate, more than a century of R&D experience across the full spectrum from top 10 pharma companies to …See details»

Guardian Therapeutics - Overview, News & Similar companies

View Guardian Therapeutics (www.guardiantherapeutics.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»

Guardian Therapeutics, Inc. | CipherBio

Explore Guardian Therapeutics, Inc.'s investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Guardian Therapeutics - Products, Competitors, Financials, …

May 16, 2018 Headquarters Location. 21 Erie Street . Cambridge, Massachusetts, 02139, United States. 781-918-6580See details»

Guardian Therapeutics LLC - Drug pipelines, Patents, Clinical trials ...

Explore Guardian Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology Platform:Aptamer drug ...See details»

Guardant Infinity™ - Guardant Health

One Technology—Powering Multiple Precision Oncology Applications. Our cutting-edge, proprietary platform delivers multiomic insights with genomic, epigenomic, and RNA-based …See details»

Nextsource | Company Profile | Guardian Therapeutics

Explore the company profile of Guardian Therapeutics (guardiantherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»

Guardian Therapeutics - VentureRadar

Develops aptamer therapeutics through discovery and research, utilizing nucleic acids that bind to specific target molecules for medical applications.See details»

Therapeutic Areas | Guardian Therapeutics

Dermatology. Aptamer with high affinity and specificity for IL23 is currently being evaluated for use in autoimmune skin disease as a topical, selective, immunomodulator with locally restricted …See details»

Guardian Therapeutics LLC (Guardian Therapeutics LLC) - 药物管 …

May 7, 2025 了解Guardian Therapeutics LLC (Guardian Therapeutics LLC)公司的药物管线,治疗领域,技术平台,以及它的,疾病领域:肿瘤,技术平台:适配体药物偶联物,药 …See details»

linkstock.net © 2022. All rights reserved